The Effects of an Ergot Alkaloid Derivative (Hydergine) on Aspects of Psychomotor Performance, Arousal, and Cognitive Processing Ability
- 12 November 1979
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 19 (11) , 726-732
- https://doi.org/10.1002/j.1552-4604.1979.tb01643.x
Abstract
Hydergine, 12 mg/day for 2 wk, has some direct activity on a variety of tasks of mental and cognitive performance. Biochemical findings implicate that the ergot alkaloids (particularly co-dergocrine, Hydergine) in cellular activity are likely to increase cortical arousal and awareness. The high dose of Hydergine used in this volunteer study was well tolerated and produced significant results on individual measures of CNS activity which might suggest the use of similar doses in patient populations. The findings of a hangover of activity after drug withdrawal and the fact that some CNS activity (serial subtraction of 17s) is not obvious until 2 wk of medication would suggest the need for pharmacokinetic measures to be taken in conjunction with psychologic assessments. Apparently a 2 wk schedule of repeated doses is the minimum required to produce an effect on CNS activity, but even with such a dose regimen it appears that the drug continues to exert some effect after its withdrawal.This publication has 7 references indexed in Scilit:
- Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters†Nature, 1976
- A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.Current Medical Research and Opinion, 1974
- An Ergot Alkaloid Preparation (Hydergine) versus Papaverine in Treating Common Complaints of the Aged: Double‐Blind StudyJournal of the American Geriatrics Society, 1973
- A clinical trial comparing 'Hydergine' with placebo in the treatment of cerebrovascular insufficiency in elderly patientsCurrent Medical Research and Opinion, 1973
- Two trials comparing 'Hydergine' with placebo in the treatment of patients suffering from cerebrovascular insufficiencyCurrent Medical Research and Opinion, 1973
- An Ergot Alkaloid Preparation (Hydergine) in Geriatric TherapyJournal of the American Geriatrics Society, 1972
- The Actions of Hydergine® on the BrainPharmacology, 1968